Cell and gene therapies are moving from clinical proof to commercial-scale challenges that demand new manufacturing and access strategies. Advanced Therapies 2027 gathers technical and commercial leaders to tackle those operational bottlenecks.
Practical details for Advanced Therapies 2027
Advanced Therapies 2027 runs 9 to 10 March 2027 at ExCeL London. The format mixes conference tracks and an exhibition focused on the full ATMP value chain across two days.
Key numbers attendees and exhibitors
The event lists over 3,000 attendees, more than 300 speakers and upwards of 200 exhibitors. The program also features around 75 biotech start-ups, creating a compact schedule that combines technical sessions with an exhibition floor.
Sectors and company profiles on site
Expect participation from cell therapy developers, gene therapy teams, bioprocessing solution providers and cold chain logistics specialists. Delegates include pharma and biotech companies, CMOs, clinical teams and regulatory experts, covering commercial and translational stages of product development.
Program focus and flagship topics
Content spans automation and continuous manufacturing, regulatory frameworks, reimbursement models and logistics for cold chain distribution. Tracks include autologous versus allogeneic strategies, CAR-T and next-generation delivery systems, and approaches to scale production for broader patient populations.
Speakers come from across industry, academia and regulatory bodies, enabling technical exchange on moving therapies from clinical trials to routine clinical use.
B2B prospecting tips for exhibitors and vendors
Segment targets before arrival. With over 200 exhibitors and 75 start-ups, prioritize partners that match your service offering: manufacturing scale-up, tech transfer, or supply chain solutions. Book one-to-one meetings ahead of time to secure slots during the two days.
Prepare concise technical dossiers emphasizing scalability, regulatory readiness and cost impact. Buyers at this event look for evidence of manufacturing capacity, validation data and experience in regulatory submissions. Draft a short set of diagnostic questions on capacity, timelines for tech transfer and previous files submitted to regulators.
Combine booth interactions with attendance at sessions aligned to your sales targets. Talks on manufacturing and market access are efficient venues to connect with operations and reimbursement stakeholders.
Final note and official link
If your business addresses manufacturing, logistics or market access for ATMPs, use Advanced Therapies 2027 to benchmark partners and validate commercial interest. Organize focused meetings and bring technical proof points. Find registration and full program information at the official site https://www.terrapinn.com/congress/advanced-therapies
